1 results match your criteria: "and Department of Urology Whipps Cross University Hospital[Affiliation]"
A Prospective Audit of Intermittent Anti-Androgen verses Pituitary Blockade Suggests a Bipolar Androgen Type Strategy May Be Safe in Untreated Prostate Cancer.
Urol Int
September 2018
Wolfson Institute of Preventive Medicine, Queen Mary University of London, and Department of Urology Whipps Cross University Hospital, London, United Kingdom.
Objective: A locally advanced Gleason 4 + 4 prostate cancer patient who was on self-medication with intermittent anti-androgen monotherapy (iAAm) over 14 years suggested that raised testosterone was not dangerous and this suggestion needed investigating.
Patients: Others who were on AA continuously were recruited to ongoing audit of intermittent hormone therapy (IHT) and iAAm outcomes were compared with intermittent LHRH therapy (iLHRH or iMAB).
Results: Between 1994 and 2007, 111 patients sought IHT because of side effects of treatment.